Hottest Stocks
(Over $10)
Hottest Stocks
($2-$10)
Biggest Losers
(Over $10)
Biggest Losers
($2-$10)
Hottest
Industries
Hottest
Sectors
EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for ICON PLC (ICLR : NSDQ)
 
 • Company Description   
ICON plc is a global full service clinical research organisation. The company provides contract clinical research services to the pharmaceutical industry worldwide.

Number of Employees: 38,330

 
 • Price / Volume Information   
Yesterday's Closing Price: $209.15 Daily Weekly Monthly
20 Day Moving Average: 517,027 shares
Shares Outstanding: 81.39 (millions)
Market Capitalization: $17,022.72 (millions)
Beta: 0.97
52 Week High: $313.00
52 Week Low: $199.01
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week -15.52% -7.80%
12 Week -5.04% -0.03%
Year To Date -32.47% -21.28%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
SOUTH COUNTY BUSINESS PARK LEOPARDSTOWN
-
DUBLIN,L2 00000
IRL
ph: 353-1291-2000
fax: 353-1247-6260
None http://www.iconplc.com
 
 • General Corporate Information   
Officers
Steve Cutler - Chief Executive Officer
Ciaran Murray - Chairman
Brendan Brennan - Chief Financial Officer
John Climax - Director
Joan Garahy - Director

Peer Information
ICON PLC (CHCR)
ICON PLC (ESRX)
ICON PLC (MYDP)
ICON PLC (GBCS)
ICON PLC (LAXAF)
ICON PLC (IPCM)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: Medical Services
Sector: Medical
CUSIP: G4705A100
SIC: 8731
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 03/01/22
Next Expected EPS Date: 07/20/22
Share - Related Items
Shares Outstanding: 81.39
Most Recent Split Date: 8.00 (2.00:1)
Beta: 0.97
Market Capitalization: $17,022.72 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $2.52 Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $10.67 Payout Ratio: 0.00
Number of Estimates in the Fiscal Year Consensus: 1.00 Change In Payout Ratio: 0.00
Estmated Long-Term EPS Growth Rate: 18.24% Last Dividend Paid: NA - $0.00
Next EPS Report Date: 07/20/22  
 

 • Fundamental Ratios
P/E
Current FY Estimate: 19.60
Trailing 12 Months: 21.54
PEG Ratio: 1.07
Price Ratios
Price/Book: 2.11
Price/Cash Flow: 18.25
Price / Sales: 2.61
EPS Growth
vs. Year Ago Period: 26.21%
vs. Previous Quarter: 6.56%
Sales Growth
vs. Year Ago Period: 121.60%
vs. Previous Quarter: 0.88%
ROE
03/31/22 - 11.33
12/31/21 - 12.71
09/30/21 - 15.50
ROA
03/31/22 - 5.31
12/31/21 - 6.04
09/30/21 - 7.59
Current Ratio
03/31/22 - 1.13
12/31/21 - 1.19
09/30/21 - 1.36
Quick Ratio
03/31/22 - 1.13
12/31/21 - 1.19
09/30/21 - 1.36
Operating Margin
03/31/22 - 11.35
12/31/21 - 11.59
09/30/21 - 12.26
Net Margin
03/31/22 - 2.58
12/31/21 - 2.79
09/30/21 - 4.09
Pre-Tax Margin
03/31/22 - 3.21
12/31/21 - 3.59
09/30/21 - 5.09
Book Value
03/31/22 - 99.14
12/31/21 - 99.11
09/30/21 - 97.91
Inventory Turnover
03/31/22 - -
12/31/21 - -
09/30/21 - -
Debt-to-Equity
03/31/22 - 0.63
12/31/21 - 0.67
09/30/21 - 0.74
Debt-to-Capital
03/31/22 - 38.67
12/31/21 - 40.01
09/30/21 - 42.43
 

Powered by Zacks Investment Research ©